RegenMed Circles’ Post

View organization page for RegenMed Circles

5,278 followers

REAPPLIX PRIVATE CIRCLE FOR DIABETIC FOOT ULCERS Reapplix, an international wound care company, has recently launched a RegenMed Private Circle aggregating clinical and long-term outcomes data on its personalized diabetic foot ulcer product. The diabetic foot ulcer market value is estimated at $5.2 billion. About 60% of all patients experience a wound that does not heal. If the severity of a wound progresses to grade 4 or 5, the cost of treatment is eight times higher than a grade 1 or 2 wound. For about 20% of patients, treatment ends in amputation within one year. The Reapplix Circle will help the company, its clinical customers, and their patients further support the safety and efficacy of its products. For more information on this Circle, including applying to join, see here: https://lnkd.in/evVcz8ch #collaboration #realworlddata #valuebasedcare

  • text
Jennifer Gardner

Reapplix Clinical Director, East

4mo

So glad to be working with you and excited to see what we can do together!

To view or add a comment, sign in

Explore topics